Low additive effect of hydroxychloroquine on Japanese patients with systemic lupus erythematosus taking calcineurin inhibitor.

Hironari HanaokaHarunobu IidaTomofumi KiyokawaYukiko TakakuwaKimito Kawahata

Published in: International journal of rheumatic diseases (2018)

The addition of HCQ reduced disease activity, PSL dose, and flares in Japanese SLE patients but conferred less additive clinical efficacy when added to CNIs.

Keyphrases

disease activity
systemic lupus erythematosus
rheumatoid arthritis
end stage renal disease
rheumatoid arthritis patients
ankylosing spondylitis
ejection fraction
chronic kidney disease
newly diagnosed
juvenile idiopathic arthritis
prognostic factors
patient reported outcomes